(Q39920161)

15 September 2017

Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype (English)

1 reference

15 September 2017

9

Hans-Georg Rammensee

1 reference

15 September 2017

10

Stefan Stevanović

1 reference

15 September 2017

Nina Hillen

1

1 reference

15 September 2017

Gabor Mester

2

1 reference

15 September 2017

Claudia Lemmel

3

1 reference

15 September 2017

Andreas O Weinzierl

4

1 reference

15 September 2017

Margret Müller

5

1 reference

15 September 2017

Dorothee Wernet

6

1 reference

15 September 2017

Jörg Hennenlotter

7

1 reference

15 September 2017

Arnulf Stenzl

8

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

European Journal of Immunology

15 September 2017

1 reference

15 September 2017

38

1 reference

15 September 2017

2993-3003

1 reference

15 September 2017

11

1 reference

Identifiying human MHC supertypes using bioinformatic methods.

15 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

Simultaneous prediction of binding capacity for multiple molecules of the HLA B44 supertype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

Toward a definition of self: proteomic evaluation of the class I peptide repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

The peptide-binding motif for the human transporter associated with antigen processing

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Identification of peptide vaccine candidates sharing among HLA-A3+, -A11+, -A31+, and -A33+ cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Amino acid 95 causes strong alteration of peptide position Pomega in HLA-B*41 variants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Minimal phenotype panels. A method for achieving maximum population coverage with a minimum of HLA antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell Recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Prediction of an HLA-B44 binding motif by the alignment of known epitopes and molecular modeling of the antigen binding cleft

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Structural principles that govern the peptide-binding motifs of class I MHC molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Optimization of the MHC class I peptide cargo is dependent on tapasin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Molecular structure of human histocompatibility antigens: the HLA-C series

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

HLA class I binding motifs derived from random peptide libraries differ at the COOH terminus from those of eluted peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

A cryptic vascular endothelial growth factor T-cell epitope: identification and characterization by mass spectrometry and T-cell assays

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

SYFPEITHI: database for MHC ligands and peptide motifs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838632

7 January 2021

Identifiers

DOI

10.1002/EJI.200838632

1 reference

15 September 2017

1 reference